Clinical trial design issues in the era of targeted therapies

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Joan H Schiller

Abstract

Although our lack of effective therapies mandates the development of new, molecularly targeted therapies, a number of issues in the design of clinical trials and their end points remain to be considered.

References

Jul 15, 1994·Statistics in Medicine·S WieandJ R O'Fallon
Jul 15, 1994·Statistics in Medicine·M BaumK Abrams
Jul 12, 2002·Statistics in Medicine·Seth M Steinberg, David J Venzon
Dec 24, 2002·Biometrics·Lurdes Y T InoueDonald A Berry
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga

❮ Previous
Next ❯

Citations

Jul 2, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Janakiraman SubramanianRamaswamy Govindan
Feb 13, 2008·Nature Clinical Practice. Oncology·Whitney A SpannuthRobert L Coleman
Sep 24, 2005·The Oncologist·Natalie M G M AppelsJan H M Schellens
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gary J KelloffDaniel C Sullivan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Nature Clinical Practice. Urology
Johannes Vieweg, Jens Dannull
Gastroenterology Research and Practice
A Greystoke, S A Mullamitha
© 2022 Meta ULC. All rights reserved